Mitochondrial Dysfunction
From cellular energy to visible skin vitality —
the science behind energized, resilient skin.
Mitochondrial dysfunction is one of the 12 Hallmarks of Skin Aging, classified as an antagonistic hallmark: initially a protective stress response, it becomes damaging over time.
As mitochondria lose efficiency, skin cells produce less ATP, generate excess reactive oxygen species (ROS), and enter senescence, impairing collagen synthesis, barrier function, and regenerative capacity. Substantiating a cosmetic claim at this level requires functional assays, not just marker detection.
The cosmetics market is converging on longevity science. Brands that demonstrate an ingredient’s effect on cellular energy metabolism, rather than surface hydration or wrinkle reduction alone, are staking out a scientifically differentiated position. That requires purpose-built models and quantifiable readouts.
At QIMA Life Sciences, we design mitochondrial studies around your specific claim objective: from early ingredient screening to multi-readout evidence packages structured for regulatory claim dossiers.
On this page:
Mitochondria regulate ATP production, ROS balance, and the initiation of apoptosis. In skin cells, age-related mitochondrial decline creates a cascade of bioenergetic deficits that drive structural aging long before visible signs appear:
These disruptions manifest as fine lines, reduced elasticity, impaired barrier function, and altered skin tone. Demonstrating that your ingredient acts upstream on the energy deficit driving these changes is the scientific foundation of a credible skin longevity claim.
Reduced ATP production compromises keratinocyte turnover and extracellular matrix maintenance, directly affecting the skin’s capacity to repair and regenerate. Evaluating this mechanism requires real-time measurement of mitochondrial respiration, not endpoint markers.
An imbalance between ROS production and antioxidant defenses induces oxidative damage to proteins, lipids, and DNA, activating senescence pathways in dermal fibroblasts and keratinocytes. ROS quantification in relevant cell models provides a mechanistic readout usable directly in a claims file.
With age, mitochondrial integrity deteriorates: membrane potential decreases, biogenesis slows, and the fusion/fission balance shifts. Fluorescence-based structural imaging in ex vivo human skin, including Mitofusin-2 (Mfn2) quantification as a marker of fusion activity, captures these changes at the tissue level.
These bioenergetic changes translate into observable skin aging outcomes:
Substantiating a claim at this level means showing your ingredient shifts a functional parameter, not just co-localising with a marker. That is the standard QIMA Life Sciences applies when structuring a study.
STRUCTURAL INTEGRITY LEVEL
Test: Mitofusin-2 (Mfn2) expression
Interest: Mitofusin-2 controls mitochondrial fusion, the process by which mitochondria merge to maintain a healthy, connected network. Its decline under stress reflects loss of structural integrity.
Method: Immunofluorescence imaging
Model: Ex vivo human skin, UV stress model
Interpretation of results: UV stress reduced Mfn2 signal versus control. Product pretreatment partially restored expression, indicating protection of the mitochondrial fusion machinery.
CELLULAR HEALTH LEVEL
Test: Mitochondrial membrane potential
Interest: Membrane potential is one of the most reliable indicators of mitochondrial health. Depolarisation signals functional impairment and precedes cell damage.
Method: JC-1 ratiometric fluorescence (red/green ratio)
Model: Normal human epidermal keratinocytes (NHEK), urban dust stress model
Interpretation of results: Urban dust significantly reduced the red/green JC-1 fluorescence ratio versus control, indicating membrane depolarisation and mitochondrial impairment.
MITOCHONDRIAL MASS & METABOLIC LEVEL
Test: Citrate synthase expression
Interest: Citrate synthase is a rate-limiting enzyme of the TCA cycle (the cell’s central energy cycle) and a recognised proxy for mitochondrial mass. Its level reads out both metabolic capacity and the size of the functional mitochondrial pool.
Method: Enzymatic expression quantification
Model: Oxidative stress model
Interpretation of results: Oxidative stress reduced citrate synthase to 57 ± 9% of control. Product pretreatment restored it to 98 ± 2% — near-complete preservation of mitochondrial mass under stress. The numeric restoration gives a defensible, quantified protection readout.
FUNCTIONAL ENERGY LEVEL
Test: Mitochondrial respiration (Seahorse OCR)
Interest: Oxygen consumption rate is the most direct functional readout of mitochondrial respiration. A single run resolves three phases — basal respiration, ATP-linked respiration, and maximal respiratory capacity — so you measure energy output itself, not a static marker.
Method: Seahorse XF real-time oxygen consumption rate (OCR) profiling
Model: Normal human epidermal keratinocytes (NHEK), cortisol-induced metabolic stress
Interpretation of results: Cortisol reduced OCR across all three phases versus control, confirming impaired capacity to produce ATP. The assay quantifies whether an active restores respiration under stress — a functional efficacy readout that goes straight into a claims file.
Get the full scientific overview of mitochondrial dysfunction, assay protocols, and data highlights.
What cell types are suitable for mitochondrial dysfunction assays?
Primary human dermal fibroblasts (NHDF) and epidermal keratinocytes (NHEK) are the primary cell types used, sourced from a bank of over 300 donors covering a range of ages, sexes, and anatomical sites. 3D reconstructed skin models and ex vivo human skin explants are also compatible for structural and imaging readouts. Each assay is optimised per cell type and study objective.
What does the Seahorse assay measure and why is it relevant for cosmetic claims?
The Seahorse XF assay measures oxygen consumption rate (OCR) in real time, providing a quantitative readout of mitochondrial respiration across 3 key phases: basal respiration, ATP-linked respiration, and maximal respiratory capacity. These parameters directly support claims related to skin energising, mitochondrial fitness, and cellular vitality under EU Cosmetics Regulation 1223/2009.
Can mitochondrial assays be combined with other hallmark evaluations?
Yes. Our modular study design supports parallel testing of multiple hallmarks within a single protocol. Mitochondrial dysfunction assays can be combined with senescence markers (SA-β-gal, p16, p21), inflammaging readouts (IL-6, IL-8, TNF-α), oxidative stress panels, or telomere attrition assays.
Can the data generated be integrated into a regulatory claim dossier?
Yes. QIMA Life Sciences provides raw data, statistical analysis, and a narrative study report structured to support claim substantiation files under EU Cosmetics Regulation 1223/2009.
Is this assay available for ex vivo skin models, or only in vitro?
Both. The mitochondrial assay portfolio applies to 2D in vitro models (primary keratinocytes and fibroblasts) and to ex vivo human skin explants, including a 3D ex vivo model of human skin mimicking intrinsic aging. Model selection is guided by the study objective and the claims to be substantiated. Contact our team for more info.
At QIMA Life Sciences, we specialize in providing comprehensive solutions for studying skin aging and longevity through validated models at both preclinical and clinical levels.
Our dedication to scientific innovation drives us to develop cutting-edge models and approaches, staying aligned with the latest advancements in longevity research.
PRECLINICAL SOLUTIONS
‘Speed-ageing’ of human skin in serum-free organ culture ex vivo
CLINICAL SOLUTIONS
SCAWA scales: A new digital tool for wrinkles clinical grading based on AI
Introduction
Our Solutions
Main Conclusions
